Wakamoto PharmaceuticalLtd Management
Management criteria checks 2/4
Wakamoto PharmaceuticalLtd's CEO is Arata Igarashi, appointed in Apr 2022, has a tenure of 2.75 years. directly owns 0.15% of the company’s shares, worth ¥11.98M. The average tenure of the management team and the board of directors is 2 years and 9.2 years respectively.
Key information
Arata Igarashi
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.8yrs |
| CEO ownership | 0.2% |
| Management average tenure | 2yrs |
| Board average tenure | 9.2yrs |
Recent management updates
Recent updates
CEO
Arata Igarashi (66 yo)
2.8yrs
Tenure
Mr. Arata Igarashi serves as President at Wakamoto Pharmaceutical Co.,Ltd since April 2022 and serves as its Chairman. He had been Senior Managing Director and General Manager of Administration Headquarter...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Chairman | 2.8yrs | no data | 0.15% ¥ 12.0m | |
| Head of Public Relations Office | no data | no data | no data | |
| Head of Global Bus HQ | no data | no data | 0.066% ¥ 5.2m | |
| MD, Head of Healthcare Business Department & Director | less than a year | no data | 0.078% ¥ 6.1m | |
| GM of Pharmaceutical Development Division & Product Strategy Department and Director | 2.6yrs | no data | 0.043% ¥ 3.4m | |
| Senior Executive Officer | 2yrs | no data | no data | |
| Operating Officer | 2yrs | no data | no data | |
| GM of Production Headquarters | no data | no data | 0.032% ¥ 2.5m |
2.0yrs
Average Tenure
61.5yo
Average Age
Experienced Management: 4512's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Chairman | 13.6yrs | no data | 0.15% ¥ 12.0m | |
| Head of Global Bus HQ | 11.8yrs | no data | 0.066% ¥ 5.2m | |
| MD, Head of Healthcare Business Department & Director | 10.8yrs | no data | 0.078% ¥ 6.1m | |
| GM of Pharmaceutical Development Division & Product Strategy Department and Director | 2.6yrs | no data | 0.043% ¥ 3.4m | |
| GM of Production Headquarters | less than a year | no data | 0.032% ¥ 2.5m | |
| Outside Independent Director | 7.6yrs | no data | no data | |
| Director | 15.6yrs | no data | 0.22% ¥ 17.0m | |
| Independent Outside Director | 1.6yrs | no data | no data |
9.2yrs
Average Tenure
65yo
Average Age
Experienced Board: 4512's board of directors are considered experienced (9.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 15:51 |
| End of Day Share Price | 2025/01/20 00:00 |
| Earnings | 2012/03/31 |
| Annual Earnings | 2012/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Wakamoto Pharmaceutical Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Company Forecast |